These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22844323)

  • 1. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm.
    Li L; Sima X; Bai P; Zhang L; Sun H; Liang W; Liu J; Zhang L; Gao L
    Clin Dev Immunol; 2012; 2012():567586. PubMed ID: 22844323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
    Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
    Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
    Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L
    Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
    Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
    Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
    Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
    Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
    Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
    J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
    Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
    Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis.
    Jia F; Sun R; Li J; Li Q; Chen G; Fu W
    Genet Test Mol Biomarkers; 2016 Jul; 20(7):398-401. PubMed ID: 27227383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma.
    Li J; Liu X; Qiao Y; Qi R; Liu S; Guo J; Gui Y; Li J; Yu H
    Front Oncol; 2018; 8():413. PubMed ID: 30319976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.
    Gao LB; Li LJ; Pan XM; Li ZH; Liang WB; Bai P; Zhu YH; Zhang L
    Biol Chem; 2013 Mar; 394(3):415-20. PubMed ID: 23183747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
    Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
    Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
    Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
    Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers.
    Li L; Zhu J; Lu T; Liu W; Tang J; Zhang J; Wang Y; Li Y; Li S; Zhou H; Xia H; He J; Cheng J
    Transl Oncol; 2019 Oct; 12(10):1282-1288. PubMed ID: 31325764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
    Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
    Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of TP53 rs1042522 G > C, MDM2 rs2279744 T > G, and miR-34b/c rs4938723 T > C polymorphisms with aneuploidy pregnancy susceptibility.
    Chan Y; Xu W; Feng Y; Zhang Y; Li S; Geng Z; Liu Z; Zhao Q; Zhang J; Zhu B
    BMC Pregnancy Childbirth; 2023 Aug; 23(1):624. PubMed ID: 37648962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
    Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
    Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of miR-34b/c polymorphisms to the risk of ischemic stroke.
    Wei G; Liao C; Jian C; Liang L; Liu J; Tang Y; Wei Y
    J Hypertens; 2020 Aug; 38(8):1481-1487. PubMed ID: 32149930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.
    Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C
    Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between rs4938723 polymorphism and the risk of primary open-angle glaucoma (POAG) in a Chinese population.
    Zhang J; Wang L
    J Cell Biochem; 2019 Aug; 120(8):12875-12886. PubMed ID: 30861198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.